Method of reducing the possibility of transmission of spongiform encephalopathy diseases by blood products

Patent Citations (8)

Non-Patent Literature (40)

• Arya, “Creutzfeldt-Jakob Disease and blood transfusion,” Br Med J, vol. 303, p. 522 (1991).Applicant
• Bradley, “The Research Programme on Transmissible Spongiform Encephalopathies in Britain With Special Reference to Bovine Spongiform Encephalopathy,” Dev Biol Stand, vol. 80, pp. 157-170 (1993).Applicant
• Brown et al, “‘Friendly fire’ in medicine: hormones, homografts, and Creutzfeldt-Jakob disease”, The Lancet, vol. 340, pp. 24-27 (1992).Applicant
• Brown, “Infectious Cerebral Amyloidosis: Clinical Spectrum, Risks and Remedies,” Dev Biol Stand, vol. 80, pp. 91-101 (1992).Applicant
• Brown, “Can Creutzfeldt-Jakob disease be transmitted by transfusion?,” Current Opinion in Hematology, vol. 2, pp. 472-472-477 (1995).Applicant
• Bruce et al, “Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier,” Phil. Trans. R. Soc. Lond. B, vol. 343, pp. 405-411 (1994).Applicant
• Casaccia et al, “Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie,” Arch Virol, vol. 108, pp. 145-149 (1989).Applicant
• Clarke et al, “Presence of the Transmissible Agent of Scrapie in the Serum of Affected Mice and Rats,” The Veterinary Record, vol. 80, No. 16, p. 504 (1967).Applicant
• Collinge et al, “Less beef, more brain,” The Lancet, vol. 347, pp. 915-917 (1996).Applicant
• Contreras et al, “Creutzfeldt-Jakob Disease and blood transfusion,” Br Med J, vol. 303, p. 187 (1991).Applicant
• Dealler, “Bovine Spongiform Encephalopathy (BSE): The Potential Effect of the Epidemic on the Human Population,” British Food Journal, vol. 95, pp. 22-34 (1993).Applicant
• Deslys et al, “Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease,” The Lancet, vol. 343, pp. 848-849 (1994).Applicant
• Eklund et al, “Pathogenesis of Scrapie Virus Infection in the Mouse,” The Journal of Infectious Diseases, vol. 117, pp. 15-22 (1967).Applicant
• Esmonde et al, “Creutzfeldt-Jakob disease and blood transfusion,” The Lancet, vol. 341, pp. 205-207 (1993).Applicant
• Field et al, “Scrapie Agent in Blood,” The Veterinary Record, vol. 83, No. 4, pp. 109-110 (1968).Applicant
• Gajdusek et al, “Experimental Transmission of a Kuru-Like Syndrome to Chimpanzees,” Nature, vol. 209, pp. 794-796 (1966).Applicant
• Gibbs et al, “Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee,” Science, vol. 161, pp. 388-389 (1968).Applicant
• Hadlow et al, “Course of Experimental Scrapie Virus Infection in the Goat,” The Journal of Infectious Diseases, vol. 129, No. 5, pp. 559-567 (1974).Applicant
• Heye et al, “Creutzfeldt-Jakob disease and blood transfusion,” The Lancet, vol. 343, pp. 298-299 (1994).Applicant
• Kimberlin et al, “Incubation Periods of Six Models of Intraperitoneally Injected Scrapie Depend Mainly on the Dynamics of Agent Replication within the Nervous System and Not the Lymphoreticular System,” J. gen. Virol., vol. 69, pp. 2953-2960 (1988).Applicant
• Kimberlin et al, “Bovine Spongiform Encephalopathy,” Ann NY Acad Sci, vol. 724, pp. 210-220 (1989).Applicant
• Klein et al, “Transmission of Creutzfeldt-Jakob Disease by blood transfusion,” The Lancet, vol. 341, p. 768 (1993).Applicant
• Kuroda et al, “Creutzfeldt-Jakob Disease in Mice: Persistent Viremia and Preferential Replication of Virus in Low-Density Lymphocytes,” Infection and Immunity, vol. 41, No. 1, pp. 154-161 (1983).Applicant
• Manuelidis, “Transmission of Creutzfeldt-Jakob Disease from Man to the Guinea Pig,” Science, vol. 190, pp. 571-572 (1975).Applicant
• Manuelidis et al, “Viremia in Experimental Creutzfeldt-Jakob Disease,” Science, vol. 200, pp. 1069-1071 (1978).Applicant
• Manuelidis et al, “Transmission to Animals of Creutzfeldt-Jakob Disease From Human Blood,” The Lancet, pp. 896-897 (1985).Applicant
• Manuelidis et al, “Transmission studies from blood of Alzheimer disease patients and healthy relatives,” Proc. Natl. Acad. Sci. USA, vol. 85, pp. 4898-4901 (1988).Applicant
• Marsh et al, “Transmissible Mink Encephalopathy: Studies on the Peripheral Lymphocyte,” Infection and Immunity, vol. 7, pp. 352-355 (1973).Applicant
• Marsh, “Bovine spongiform encephalopathy: a new disease of cattle?,” Arch Virol (Suppl), vol. 7, pp. 255-259 (1993).Applicant
• Morgan, “Blood to be screened to CJD,” BMJ, vol. 313, p. 441 (1996).Applicant
• Patterson et al, “Bovine spongiform encephalopathy and the public health,” Journal of Public Health Medicine, vol. 13, No. 3, pp. 261-268 (1995).Applicant
• Tamai et al, “Demonstration of the Transmissible Agent in Tissue From a Pregnant Woman with Creutzfeldt-Jakob Disease,” N Eng J Med, vol. 327, p. 649 (1992).Applicant
• Tateishi et al, “Experimental Transmission of Human Subacute Spongiform Encephalopathy to Small Rodents,” Acta Neuropathologica, vol. 51, pp. 127-134 (1980).Applicant
• Tateishi et al, “Unconventional Pathogens Causing Spongiform Encephalopathies Absent in Blood Products,” Journal of Medical Virology, vol. 16, pp. 11-15 (1985).Applicant
• Tateishi, “Transmissible of Creutzfeldt-Jakob Disease From Human Blood and Urine to Mice,” The Lancet, p. 1074 (1985).Applicant
• Watkins, “Creutzfeldt-Jakob Disease and blood transfusion,” Br Med J, vol. 302, p. 1537 (1991).Applicant
• Contreras et al, “Creutzfeldt-Jakob Disease and blood transfusion,” Br Med J, vol. 302, p. 11148 (1991).Applicant
• Diringer, “Sustained Viremia in Experimental Hamster Scrapie,” Archives of Virology, vol. 82, pp. 105-109 (1984).Applicant
• Matthews, “BSE: A Mid-Term Report Part 1,” State Vet J, vol. 2, pp. 8-11 (1992).Applicant
• Bruisten, S.M. et al., Efficiency of White Cell Filtration in a Freeze-Thaw Procedure for Removal of HIV-Infected Cells From Blood, Transfusion, 1990, 30:833-837.Examiner